Inventor · disambiguated record
Howard V. Raff
Also filed as: RAFF HOWARD · RAFF HOWARD V
15 granted patents·6 pending applications·158 citations·filing 1988–2024
94Inventor score
Files withAIMMUNE THERAPEUTICS INC7NESTLE SA6BRISTOL MYERS SQUIBB CO2ALLERGEN RES CORP1Aimmune Therapeutics1
Top patents by PatentIndex Score
21 records- 0197US10086068B2Peanut formulations and uses thereofAIMMUNE THERAPEUTICS INC·Filed 2016·Granted Oct 2, 2018·16 cites·38 claims
- 0296US10512686B2Peanut formulations and used thereofAIMMUNE THERAPEUTICS INC·Filed 2019·Granted Dec 24, 2019·7 cites·24 claims
- 0396US9492535B2Peanut formulations and uses thereofAIMMUNE THERAPEUTICS INC·Filed 2014·Granted Nov 15, 2016·23 cites·33 claims
- 0494US10918676B2Egg protein formulations and methods of manufacture thereofAIMMUNE THERAPEUTICS INC·Filed 2019·Granted Feb 16, 2021·5 cites·21 claims
- 0593US10653773B2Peanut formulations and uses thereofAIMMUNE THERAPEUTICS INC·Filed 2018·Granted May 19, 2020·6 cites·28 claims
- 0693US9198869B2Manufacture of peanut formulations for oral desensitizationALLERGEN RES CORP·Filed 2014·Granted Dec 1, 2015·34 cites·9 claims
- 0791US12016917B2Peanut formulations and uses thereofNESTLE SA·Filed 2020·Granted Jun 25, 2024·2 cites·32 claims
- 0890US10449118B2Manufacture of peanut formulations for oral desensitizationAIMMUNE THERAPEUTICS INC·Filed 2017·Granted Oct 22, 2019·7 cites·26 claims
- 0989US11197896B2Egg protein formulations and methods of manufacture thereofNESTLE SA·Filed 2015·Granted Dec 14, 2021·3 cites·39 claims
- 1089US2025375517A1Peanut formulations and uses thereofNESTLE SA·Filed 2024·Application pending·0 cites
- 1188US11141352B2Manufacture of peanut formulations for oral desensitizationSOC DES PRODUIT NESTLE S A·Filed 2019·Granted Oct 12, 2021·4 cites·36 claims
- 1284US12383584B2Egg protein formulations and methods of manufacture thereofNESTLE SA·Filed 2022·Granted Aug 12, 2025·0 cites·20 claims
- 1379US2023120350A1Manufacture of peanut formulations for oral desensitizationNESTLE SA·Filed 2022·Application pending·0 cites
- 1477US2023139230A1Egg protein formulations and methods of manufacture thereofNESTLE SA·Filed 2022·Application pending·0 cites
- 1573US4970070AProtective monoclonal antibody compositions for infections due to group B streptococcusGENETIC SYSTEMS CORP·Filed 1988·Granted Nov 13, 1990·25 cites·42 claims
- 1654US2016030289A1Manufacture of peanut formulations for oral desensitizationAIMMUNE THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 1751US8007815B1Combination meningitidis B/C vaccinesNOVARTIS AG·Filed 1999·Granted Aug 30, 2011·13 cites·11 claims
- 1851US2010029551A1Treatment Of Inflammatory Lung Conditions With Aerosolized Macrolide AntibioticsRAFF HOWARD V·Filed 2009·Application pending·0 cites
- 1950US5837541ACross-protective human monoclonal antibody compositionsBRISTOL MYERS SQUIBB CO·Filed 1995·Granted Nov 17, 1998·7 cites·10 claims
- 2050US5717071ACross-protective human monoclonal antibody compositionsBRISTOL MYERS SQUIBB CO·Filed 1994·Granted Feb 10, 1998·6 cites·23 claims
- 2134US2015343075A1Placebo formulations and uses thereofAimmune Therapeutics·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Howard V. Raff files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →